Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07228000 · ClinicalTrials.gov registry record · NA

Bundled Cancer Screening and Genetic Services Navigation

A NA study, sponsored by Georgetown University.

Recruiting
Registry status
NA
Development phase
820
Enrollment target

NCT07228000 is a NA study that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 820 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07228000, a NA study, is actively recruiting participants, sponsored by Georgetown University.

RECRUITING
Registry status
NA
Development phase
820 participants
Enrollment target

Study Summary

The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.

Interventions

  • BEHAVIORAL Breast cancer screening navigation
  • BEHAVIORAL Multicancer screening navigation
  • BEHAVIORAL Usual care genetics referral
  • BEHAVIORAL Pretest education + usual care genetics referral

Trial Details

FieldValue
Enrollment Target 820 participants
Start Date 2026-05-06
Est. Completion 2029-05-31
Phase NA

Sponsor

Georgetown University

227 total trials

What the Registry Record Tells You About NCT07228000

The ClinicalTrials.gov registry entry for NCT07228000 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 820 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Breast cancer screening navigation is the first listed.

NCT07228000 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07228000 about?

NCT07228000 is a clinical study titled "Bundled Cancer Screening and Genetic Services Navigation". The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to ge...

What is the current status of trial NCT07228000?

This trial is currently recruiting. It is a NA study. The enrollment target is 820 participants. The study started on 2026-05-06. Estimated completion is 2029-05-31.

What interventions are being tested in trial NCT07228000?

The interventions under investigation include: Breast cancer screening navigation (BEHAVIORAL), Multicancer screening navigation (BEHAVIORAL), Usual care genetics referral (BEHAVIORAL), Pretest education + usual care genetics referral (BEHAVIORAL).

Who is sponsoring clinical trial NCT07228000?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.